Amanda Cray

Contatto Relazioni con gli Investitori presso FUSN PHAR

Health Technology

Consumer Services

Commercial Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Christopher Leamon	M	57	FUSN PHAR	3 anni
Eric S. Hoffman	M	54	FUSN PHAR	3 anni
Maria D. Stahl	F	53	FUSN PHAR	4 anni
Eric Burak	M	-	FUSN PHAR	7 anni
Cara Ferreira	M	-	FUSN PHAR	4 anni
Dmitri Bobilev	M	-	FUSN PHAR	2 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Gregory Perry	M	63	AEGERION PHARMACEUTICALS, INC. NOVELION THERAPEUTICS INC.	2 anni
Mary Szela	F	60	AEGERION PHARMACEUTICALS, INC. NOVELION THERAPEUTICS INC.	1 anni
David I. Scheer	M	71	AEGERION PHARMACEUTICALS, INC.	13 anni
Sandy Smith	M	77	NOVELION THERAPEUTICS INC. AEGERION PHARMACEUTICALS, INC.	5 anni
Marc Beer	M	59	AEGERION PHARMACEUTICALS, INC.	5 anni
Jorge Plutzky	M	65	AEGERION PHARMACEUTICALS, INC. NOVELION THERAPEUTICS INC.	2 anni
Anne VanLent	F	76	AEGERION PHARMACEUTICALS, INC. NOVELION THERAPEUTICS INC.	4 anni
Michael Dennis Price	M	66	NOVELION THERAPEUTICS INC.	3 anni
Remi A. Menes	M	-	NOVELION THERAPEUTICS INC. AEGERION PHARMACEUTICALS, INC.	1 anni
Mary Weger	F	65	AEGERION PHARMACEUTICALS, INC.	-
Mark Dipaolo	M	53	NOVELION THERAPEUTICS INC.	1 anni
Jeffrey Hackman	M	62	NOVELION THERAPEUTICS INC.	1 anni
David J. Aubuchon	M	-	AEGERION PHARMACEUTICALS, INC.	-
Kevin Kotler	M	53	NOVELION THERAPEUTICS INC.	2 anni
Paul Thomas	M	68	AEGERION PHARMACEUTICALS, INC.	5 anni
William T. Andrews	M	60	AEGERION PHARMACEUTICALS, INC.	4 anni
Mark Corrigan	M	66	NOVELION THERAPEUTICS INC.	2 anni
Antonio Gotto	M	88	AEGERION PHARMACEUTICALS, INC.	11 anni
Sol Barer	M	76	AEGERION PHARMACEUTICALS, INC.	5 anni
Suzanne Bruhn	M	60	NOVELION THERAPEUTICS INC.	3 anni
Anne Cook	F	62	AEGERION PHARMACEUTICALS, INC.	4 anni
Ben Harshbarger	M	55	AEGERION PHARMACEUTICALS, INC.	4 anni
Brian Thomson	M	55	AEGERION PHARMACEUTICALS, INC.	4 anni
Stephen J. Moloney	M	-	AEGERION PHARMACEUTICALS, INC.	1 anni
Murray Stewart	M	63	NOVELION THERAPEUTICS INC.	1 anni
Joseph Shulman	M	49	NOVELION THERAPEUTICS INC.	5 anni
Sachiyo Minegishi	F	46	AEGERION PHARMACEUTICALS, INC.	4 anni
David Allmond	M	54	AEGERION PHARMACEUTICALS, INC.	-
Linda Buono	M	58	AEGERION PHARMACEUTICALS, INC.	-
Roger W. Louis	M	69	AEGERION PHARMACEUTICALS, INC.	1 anni
Eric Curtis	M	56	AEGERION PHARMACEUTICALS, INC.	2 anni
Donald Stern	M	78	AEGERION PHARMACEUTICALS, INC.	1 anni
Carolina Alarco	F	-	AEGERION PHARMACEUTICALS, INC.	5 anni
John Orloff	M	66	AEGERION PHARMACEUTICALS, INC.	-
Mark Rothera	M	61	AEGERION PHARMACEUTICALS, INC.	1 anni
Mark Sumeray	M	58	AEGERION PHARMACEUTICALS, INC.	5 anni
Nic G. Scalfarotto	M	-	AEGERION PHARMACEUTICALS, INC.	-
Craig Fraser	M	59	AEGERION PHARMACEUTICALS, INC.	1 anni
Mark J. Fitzpatrick	M	61	AEGERION PHARMACEUTICALS, INC.	4 anni
Muffy Carter	F	71	AEGERION PHARMACEUTICALS, INC.	5 anni
Jason Aryeh	M	55	NOVELION THERAPEUTICS INC.	6 anni
Geoffrey F. Cox	M	80	NOVELION THERAPEUTICS INC.	-
Alexander Nolte	M	52	AEGERION PHARMACEUTICALS, INC.	2 anni

Statistiche

Paese	Relazioni	% del totale
Stati Uniti	33	67.35%
Canada	22	44.90%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni

Borsa valori
Insiders
Amanda Cray
Contatti personali